3D-printed Bone Models in Addition to CT Imaging for Intra-articular Fracture Repair (SPRINT)

July 19, 2022 updated by: Dr. Christian Xinshuo Fang, The University of Hong Kong

Sterilised 3D-PRINTed Bone Models in Addition to Conventional CT Imaging for Operative Visualisation in Complex Intra-articular Fracture Repair - A Multi-centre, Double-blind Randomised Controlled Trial

The purpose of this study is to compare the effectiveness of 3D-printed bone models in addition to CT imaging versus CT imaging alone on surgical quality and operation time for patients undergoing surgical repair of intra-articular fractures.

Study Overview

Detailed Description

Surgical fixation of intra-articular fractures is a technically demanding task that poses significant challenges to orthopaedic surgeons. Articular fragments may be comminuted, depressed, or impacted, and neighbouring soft tissue is often heavily compromised. Furthermore, aggressive surgical dissection is typically necessary to achieve adequate visualisation, and anatomical reduction often devitalises bone fragments and invites deep infection. The management of intra-articular fractures requires a well-designed preoperative plan and a skilfully executed surgical tactic to guarantee the best possible outcome. Multiplanar reformation (CT-MPR) and three-dimensional reconstruction (CT-3DR) are imaging techniques that have enhanced intraoperative visualisation, however, accurate analysis of complex fractures remains challenging.

3D printing is a rapidly developing, low-cost technology that is already being applied across numerous contexts in orthopaedics and traumatology. 3D printed bone models can be produced from digitised CT data in a matter of hours, providing a dimensionally accurate representation of the patient's skeleton which approximates real-life visual and tactile experiences. When used in preoperative planning, these models have shown to improve surgeon communication and shorten surgical duration. Despite positive early results, few clinical studies have studied the effect of 3D bone model use on surgical outcome. The purpose of this randomised controlled trial is to compare the effectiveness of intraoperatively utilised 3D bone models in addition to conventional CT imaging on reduction quality and surgical duration versus CT imaging alone for patients undergoing surgical fixation of complex intraarticular fractures.

Patients providing informed consent will be screened for eligibility. All eligible patients will be randomly assigned in a double-blind manner (participant and outcome assessor) to receive surgical fracture fixation with or without the addition of sterilised 3D-printed bone models to standard CT imaging for intraoperative visualisation.

Study Type

Interventional

Enrollment (Anticipated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Christian Fang
  • Phone Number: 22554581
  • Email: cfang@hku.hk

Study Locations

      • Hong Kong, Hong Kong
        • Recruiting
        • Queen Mary Hospital, the University of Hong Kong
        • Contact:
          • Christian Xinshuo Fang
          • Phone Number: 22554581
        • Principal Investigator:
          • Christian Xinshuo Fang

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. age 18 years or older
  2. with intra-articular fracture of the proximal or distal humerus, proximal ulna, proximal radius, distal femur, or proximal or distal tibia (pilon fracture)
  3. requiring anticipated surgical repair of fracture
  4. with pre-operative CT scan already available as part of routine assessment

Exclusion Criteria:

  1. pathological fracture
  2. multiple fractures requiring simultaneous or staged operations
  3. fractures around the hip, pelvis and acetabulum, and any other fracture types not specified in the inclusion criteria
  4. requiring surgery within 24 hours of admission
  5. unable or unwilling to give consent to participate

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: 3D-printed models plus CT imaging
Fracture repair surgery using sterilized 3DP models, CT-MPR and CT-3DR for planning and intraoperative visualization
In addition to CT-MPR and CT-3DR, 3DP models will be used for surgical planning and intraoperative visualization.
Active Comparator: CT imaging alone
Fracture repair surgery using CT-MPR and CT-3DR for planning and intraoperative visualization
CT-MPR and CT-3DR used for surgical planning and intraoperative visualization.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality of articular surface reduction grading assessed by three-point scale
Time Frame: Immediately post-operation
The quality of articular surface reduction will be rated by two surgeons blinded to intervention allotment assessing post-operative and intraoperative fluoroscopic images. The Kappa value will be recorded for inter-observer agreement between two observers (1. Perfect reduction, 2. Observable imperfections 1-2mm, 3. Significant imperfections >2mm)
Immediately post-operation
Skin to skin duration of surgery (minutes)
Time Frame: Immediately post-operation
The skin to skin duration of the surgery will be recorded.
Immediately post-operation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total fluoroscopy time (seconds)
Time Frame: Immediately post-operation
The total intraoperative fluoroscopy time will be recorded in seconds.
Immediately post-operation
Intraoperative blood loss (mL)
Time Frame: Immediately post-operation
The patient's blood loss during the surgery will be recorded.
Immediately post-operation
Total length of skin incision (mm)
Time Frame: Immediately post-operation
The total length on the incision will be measured post operation.
Immediately post-operation
Total tourniquet time (minutes)
Time Frame: Immediately post-operation
Total time the tourniquet was applied will be recorded.
Immediately post-operation
Incidence of surgical complications
Time Frame: 3 months post-operation
Incidence of infection, neurological deficit, wound breakdown, loss of fixation, revision surgery will be recorded at follow up.
3 months post-operation
Quality of articular surface reduction grading assessed by three-point scale
Time Frame: 3 months post operation
The quality of articular surface reduction will be rated by two surgeons blinded to intervention allotment assessing post-operative and intraoperative fluoroscopic images. The Kappa value will be recorded for inter-observer agreement between two observers (1. Perfect reduction, 2. Observable imperfections 1-2mm, 3. Significant imperfections >2mm)
3 months post operation
Health-related quality of life measured by SF-12 Chinese (HK) version
Time Frame: 3 months post-operation
12-item Short Form Health Survey (SF-12), a patient-reported outcome measure of HRQOL comprised of a mental component (MCS) and physical component (PCS), each with a final score ranging from 0 (worst outcome) to 100 (best outcome).
3 months post-operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christian Fang, Dept of Orthopaedics and Traumatology, Queen Mary Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 13, 2020

Primary Completion (Anticipated)

December 31, 2023

Study Completion (Anticipated)

December 31, 2023

Study Registration Dates

First Submitted

February 5, 2021

First Submitted That Met QC Criteria

February 5, 2021

First Posted (Actual)

February 10, 2021

Study Record Updates

Last Update Posted (Actual)

July 20, 2022

Last Update Submitted That Met QC Criteria

July 19, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

Anonymized dataset to be included as supplementary data in final publication

IPD Sharing Time Frame

Within 1 year of study completion

IPD Sharing Access Criteria

Additional information available upon reasonable request of principal investigator

IPD Sharing Supporting Information Type

  • Study Protocol
  • Statistical Analysis Plan (SAP)
  • Informed Consent Form (ICF)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Humeral Fracture

Clinical Trials on 3D printed (3DP) bone models + CT imaging

3
Subscribe